Subject of Possible Rule Making: Dialysate and dialysis device manufacturers and wholesalers in home dialysis programs. The pharmacy quality assurance commission (commission) is considering amending WAC 246-945-090, 246-945-091, 246-945-092, and 246-945-093 and creating new sections in chapter 246-945 WAC to include manufacturers and distributors of dialysate and dialysis devices in home dialysis program rules under the commission's jurisdiction. The amendments under consideration are in response to statutory changes made by SHB 1675 (chapter 23, Laws of 2022).

Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: The commission is considering amending WAC 246-945-090, 246-945-091, 246-945-092, and 246-945-093 and creating new sections in chapter 246-945 WAC to align with statutory changes made by SHB 1675 (chapter 23, Laws of 2022). The amendments the commission is considering would increase patient access to dialysis devices and legend drugs used in home dialysis by allowing manufactures and wholesalers to dispense lawfully prescribed dialysis devices and legend drugs for home dialysis directly to the patient, reducing intermediary storage facility use.

Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Joshua Munroe, P.O. Box 47852, Olympia, WA 98504-7852, phone 360-502-5058, fax 360-236-2901, TTY 711, email https://fortress.wa.gov/doh/policyreview, website www.doh.wa.gov.

Additional comments: All rule-making notices will be distributed via GovDelivery. To receive notices, interested persons may sign up by going to https://public.govdelivery.com/accounts/WADOH/subscriber/new. After signing up, please click open the box labeled "Health Systems Quality Assurance." Next, click open the box labeled "Health Professions," then check the box next to "Pharmacy Quality Assurance Commission."